信达生物 内部交易概览
最近18个月交易的高管股东 | 交易次数 | 净买入(股) |
---|---|---|
The Capital Group Companies, Inc. | 12 | -7,217,224 |
Temasek Holdings (private) Limited | 2 | -433,500 |
LAV Asset Management (Hong Kong) Limited | 1 | 350,000 |
Shi Yi | 1 | 350,000 |
Yu De-chao Michael | 1 | -502,961 |
JPMorgan Chase & Co. | 0 | 0 |
交易分段汇总 | 买入数量 | 卖出数量 | 净买入(股) |
---|---|---|---|
最近1个月 | 0 | 0 | 0 |
最近3个月 | 1,869,776 | 0 | 1,869,776 |
最近6个月 | 3,162,276 | 3,456,000 | -293,724 |
最近12个月 | 8,256,776 | 8,554,461 | -297,685 |
最近18个月 | 9,696,776 | 19,093,461 | -9,396,685 |
最近36个月 | 11,639,776 | 19,093,461 | -7,453,685 |
信达生物 内部交易
信达生物 最新内部交易
Yu De-chao Michael | 2101 Beneficial owner | 2024-03-22 | - | 3,726,000 | 130,126,248 |
HK$0
|
--
|
Brown Brothers Harriman & Co. | 2502 Approved lending agent | 2024-02-05 | - | 302,000 | 81,184,081 |
HK$0
|
--
|
The Capital Group Companies, Inc. | 2201 Interest of corporation controlled by you | 2024-02-02 | 买入 | 1,869,776 | 114,164,873 |
HK$32.51
|
+20.58%
|
The Capital Group Companies, Inc. | 2201 Interest of corporation controlled by you | 2024-01-12 | 买入 | 1,292,500 | 98,058,665 |
HK$40.15
|
-2.37%
|
The Capital Group Companies, Inc. | 2201 Interest of corporation controlled by you | 2024-01-05 | 卖出 | 3,456,000 | 96,314,665 |
HK$38.69
|
+1.32%
|
The Capital Group Companies, Inc. | 2201 Interest of corporation controlled by you | 2023-10-25 | 买入 | 2,249,500 | 98,326,860 |
HK$45.93
|
-14.65%
|
Yu De-chao Michael | 2101 Beneficial owner | 2023-10-17 | 卖出 | 502,961 | 126,400,248 |
HK$44.21
|
-11.33%
|
The Capital Group Companies, Inc. | 2201 Interest of corporation controlled by you | 2023-10-12 | 卖出 | 3,324,500 | 94,341,646 |
HK$43.02
|
-8.88%
|
Citigroup Inc. | 2201 Interest of corporation controlled by you | 2023-09-13 | - | 19,243,420 | 83,851,397 |
HK$0
|
--
|
Citigroup Inc. | 2201 Interest of corporation controlled by you | 2023-09-13 | - | 856,113 | 30,844,798 |
HK$0
|
--
|